192 related articles for article (PubMed ID: 80260)
1. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
Gillette RW; Wunderlich DA
Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
[TBL] [Abstract][Full Text] [Related]
2. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.
McGrath CM; Jones RF
Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187
[TBL] [Abstract][Full Text] [Related]
3. [Effect of RNA on tumor growth in mice of lines with and without the milk factor].
Tomsons VP; Verevkina KN; Matienko NA
Dokl Akad Nauk SSSR; 1977; 232(1):217-20. PubMed ID: 188616
[No Abstract] [Full Text] [Related]
4. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
Vaage J; Medina D
Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
[TBL] [Abstract][Full Text] [Related]
5. [Changes in the properties of mammary factor carcinomas of C3H strain mice treated with exogenous RNA].
Tomsons VP; Pyrinova GB
Dokl Akad Nauk SSSR; 1980; 251(4):987-91. PubMed ID: 6156814
[No Abstract] [Full Text] [Related]
6. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
7. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
9. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
Li YX; Papkoff J; Sarkar NH
Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
[TBL] [Abstract][Full Text] [Related]
10. Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts.
Bogden AE; Kelton DE; Cobb WR; Gulkin TA; Johnson RK
Cancer Res; 1978 Jan; 38(1):59-64. PubMed ID: 618583
[No Abstract] [Full Text] [Related]
11. Experimental infection of a cat kidney cell line with the mouse mammary tumor virus.
Lasfargues EY; Lasfargues JC; Dion AS; Greene AE; Moore DH
Cancer Res; 1976 Jan; 36(1):67-72. PubMed ID: 55305
[TBL] [Abstract][Full Text] [Related]
12. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
13. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
Likhite VV
J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.
Butel JS; Dudley JP; Medina D
Cancer Res; 1977 Jun; 37(6):1892-900. PubMed ID: 192465
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
[TBL] [Abstract][Full Text] [Related]
17. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
Vaage J; Medina D
Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
[No Abstract] [Full Text] [Related]
18. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
20. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
Frey AB
J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
